IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.780
EU - Europa 2.250
AS - Asia 1.773
SA - Sud America 295
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.732
SG - Singapore 808
IE - Irlanda 430
IT - Italia 359
UA - Ucraina 316
CN - Cina 312
HK - Hong Kong 292
SE - Svezia 288
BR - Brasile 249
RU - Federazione Russa 230
FI - Finlandia 180
DE - Germania 172
VN - Vietnam 162
GB - Regno Unito 80
KR - Corea 74
FR - Francia 53
CA - Canada 27
IN - India 26
AR - Argentina 24
NL - Olanda 22
PL - Polonia 21
BE - Belgio 18
TR - Turchia 17
ZA - Sudafrica 17
AT - Austria 16
MX - Messico 15
BD - Bangladesh 14
CH - Svizzera 12
IQ - Iraq 12
RO - Romania 11
CZ - Repubblica Ceca 10
JP - Giappone 9
UZ - Uzbekistan 9
ES - Italia 8
GR - Grecia 8
LB - Libano 7
LT - Lituania 7
CO - Colombia 5
EC - Ecuador 5
ID - Indonesia 5
KE - Kenya 4
OM - Oman 4
VE - Venezuela 4
BO - Bolivia 3
JO - Giordania 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
AU - Australia 2
BG - Bulgaria 2
EU - Europa 2
KZ - Kazakistan 2
LV - Lettonia 2
PK - Pakistan 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KI - Kiribati 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
UG - Uganda 1
Totale 7.135
Salva come PNG Salva come JPEG
Città #
Singapore 547
Chandler 443
Dublin 430
Hong Kong 291
San Mateo 287
Ashburn 168
Boardman 156
Jacksonville 150
Perugia 147
Santa Clara 104
Beijing 93
Medford 82
Princeton 82
Moscow 75
Munich 74
Altamura 71
Ann Arbor 70
Seoul 69
Wilmington 65
Andover 63
Dong Ket 59
Lawrence 55
Helsinki 53
New York 39
Ho Chi Minh City 38
Los Angeles 38
Turku 37
Piscataway 32
Des Moines 30
Saint Petersburg 24
The Dalles 24
São Paulo 23
Hanoi 22
Woodbridge 21
Norwalk 20
Brooklyn 18
Redwood City 17
Frankfurt am Main 16
Shanghai 15
Brussels 14
Houston 14
Dallas 13
Espoo 13
Foligno 13
Rio de Janeiro 13
Rome 13
San Paolo di Civitate 13
Amsterdam 12
Chicago 12
Falkenstein 12
Johannesburg 12
London 12
Stockholm 12
Warsaw 12
Atlanta 11
Boston 11
San Francisco 11
Izmir 10
Denver 9
Guangzhou 9
Montreal 9
Tokyo 9
Hefei 8
Orem 8
Redmond 8
Bologna 7
Brasília 7
Bucharest 7
Chennai 7
Belo Horizonte 6
Brno 6
Florence 6
Oklahoma City 6
Phoenix 6
Seattle 6
Vienna 6
Ancona 5
Auburn Hills 5
Columbus 5
Den Haag 5
Falls Church 5
Manchester 5
Nuremberg 5
Ottawa 5
Quito 5
Tashkent 5
Baghdad 4
Campinas 4
Changsha 4
Da Nang 4
Dearborn 4
Deruta 4
Hangzhou 4
Philadelphia 4
Porto Alegre 4
San Diego 4
Secaucus 4
Sorocaba 4
Toronto 4
Volta Redonda 4
Totale 4.517
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 135
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 132
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 126
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 119
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 117
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 116
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 110
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 108
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 107
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 105
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 104
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 103
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 103
"Designed" grafts for HLA-haploidentical stem cell transplantation. 101
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 101
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 100
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 100
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 99
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 99
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 96
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 95
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 92
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 92
Natural killer cells: biology and application in stem-cell transplantation 90
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 90
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 90
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 90
Natural killer cell alloreactivity for leukemia therapy. 89
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 89
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 88
Cellular therapy: exploiting NK cell alloreactivity in transplantation 87
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 85
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 85
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 84
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 84
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 84
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 81
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 79
Haploidentical transplantation and natural killer cell recognition of missing self. 79
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 79
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 78
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 78
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 77
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 77
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 76
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 76
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 76
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 75
New mechanism of lymphoma-induced bone marrow aplasia 75
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 74
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 73
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 72
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 72
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 71
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 71
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 70
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 69
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 68
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 68
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 66
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 66
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 66
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 64
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 64
Jack of all trades: thymosin α1 and its pleiotropy. 64
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 64
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 64
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 62
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 62
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 62
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 62
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 62
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 61
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 61
Next generation HLA-haploidentical HSCT 59
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 59
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 58
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 57
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 57
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 56
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 55
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 54
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 52
Natural killer cells as a therapeutic tool in mismatched transplantation 51
NK cells: a lesson from mismatched hematopoietic transplantation 50
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 50
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 49
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 49
null 46
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 46
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 45
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 44
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 37
null 36
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 28
null 27
null 11
Totale 7.335
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 55 46 7 73 24 56 75
2021/2022873 14 235 29 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/20251.380 23 136 34 89 199 60 51 119 235 71 216 147
2025/20261.574 210 202 173 331 436 222 0 0 0 0 0 0
Totale 7.335